Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1755 ARTÍCULOS , VIENDO DEL 1711 AL 1725

Fractal dimension of the brain in neurodegenerative disease and dementia: A systematic review

Ziukelis ET, Mak E, Dounavi ME, Su L, T O'Brien J.

Ageing Res Rev. 2022 Aug;79:101651. doi: 10.1016/j.arr.2022.101651. Epub 2022 May 25.

Is the pathology of posterior cortical atrophy clinically predictable?

Cipriano L, Oliva M, Puoti G, Signoriello E, Bonavita S, Coppola C.

Rev Neurosci. 2022 Jun 6;33(8):849-858. doi: 10.1515/revneuro-2022-0003. Print 2022 Dec 16.

SORL1 gene mutation and octapeptide repeat insertion in PRNP gene in a case presenting with rapidly progressive dementia and cerebral amyloid angiopathy

Cencini F, Catania M, Di Fede G, Rossi G, Chalouhi KK, Manfredi C, Giaccone G, Tiraboschi P, Bersano A, Groppo E, Rosci C, Tancredi L, Campiglio L, De Grado A, Priori A, Scelzo E.

Eur J Neurol. 2022 Nov;29(11):3139-3146. doi: 10.1111/ene.15487. Epub 2022 Jul 22.

A clinicopathological study of selected cognitive impairment cases in Lothian, Scotland: enhanced CJD surveillance in the 65 + population group

Kanguru L, Logan G, Waddel B, Smith C, Molesworth A, Knight R.

BMC Geriatr. 2022 Jul 20;22(1):603. doi: 10.1186/s12877-022-03280-4.

Hyperhomocysteinemia and Dementia Associated With Severe Cortical Atrophy, but No Amyloid Burden

Reffo A, Gabelli C.

J Geriatr Psychiatry Neurol. 2022 Jan;35(1):57-61. doi: 10.1177/0891988720988910. Epub 2021 Jan 19.

Differentiating dementia with Lewy bodies from Alzheimer's disease and Parkinson's disease dementia: an update on imaging modalities

Orad RI, Shiner T.

J Neurol. 2022 Feb;269(2):639-653. doi: 10.1007/s00415-021-10402-2. Epub 2021 Jan 29.

Sex Differences in Neurodegeneration: The Role of the Immune System in Humans

Lopez-Lee C, Kodama L, Gan L.

Biol Psychiatry. 2022 Jan 1;91(1):72-80. doi: 10.1016/j.biopsych.2021.01.002. Epub 2021 Jan 8.

Emerging urinary alpha-synuclein and miRNA biomarkers in Parkinson's disease

Giri B, Seamon M, Banerjee A, Chauhan S, Purohit S, Morgan J, Baban B, Wakade C.

Metab Brain Dis. 2022 Aug;37(6):1687-1696. doi: 10.1007/s11011-021-00735-2. Epub 2021 Apr 21.

Protective properties of GLP-1 and associated peptide hormones in neurodegenerative disorders

Hölscher C.

Br J Pharmacol. 2022 Feb;179(4):695-714. doi: 10.1111/bph.15508. Epub 2021 May 29.

Prolactin and Its Altered Action in Alzheimer's Disease and Parkinson's Disease

Duc Nguyen H, Pal Yu B, Hoang NHM, Jo WH, Young Chung H, Kim MS.

Neuroendocrinology. 2022;112(5):427-445. doi: 10.1159/000517798. Epub 2021 Jun 14.

T Cells: A Growing Universe of Roles in Neurodegenerative Diseases

Dressman D, Elyaman W.

Neuroscientist. 2022 Aug;28(4):335-348. doi: 10.1177/10738584211024907. Epub 2021 Jun 23.

Traumatic Brain Injury and Risk of Neurodegenerative Disorder

Brett BL, Gardner RC, Godbout J, Dams-O'Connor K, Keene CD.

Biol Psychiatry. 2022 Mar 1;91(5):498-507. doi: 10.1016/j.biopsych.2021.05.025. Epub 2021 Jun 2.

Effectiveness of gait aid prescription for improving spatiotemporal gait parameters and associated outcomes in community-dwelling older people: a systematic review

Lee DA, Dissanayaka T, Burton E, Meyer C, Hunter SW, Suttanon P, Ekegren CL, Stout JC, Dawes H, Hill KD.

Disabil Rehabil. 2022 Oct;44(21):6139-6154. doi: 10.1080/09638288.2021.1958930. Epub 2021 Aug 10.

Multimodal retinal imaging to detect and understand Alzheimer's and Parkinson's disease

Moons L, De Groef L.

Curr Opin Neurobiol. 2022 Feb;72:1-7. doi: 10.1016/j.conb.2021.07.007. Epub 2021 Aug 14.

Src family kinases (SFKs): critical regulators of microglial homeostatic functions and neurodegeneration in Parkinson's and Alzheimer's diseases

Portugal CC, Almeida TO, Socodato R, Relvas JB.

FEBS J. 2022 Dec;289(24):7760-7775. doi: 10.1111/febs.16197. Epub 2021 Oct 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias